Test Price
2,800 AED✅ Home Collection Available
SLC22A9 Gene Autism Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM–11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Price: 2,800 AED (includes genetic counseling and home collection). Turnaround Time: 3–4 weeks.
Test Overview & Methodology
The SLC22A9 Gene Autism NGS Test is a targeted next-generation sequencing assay that analyzes the coding region and splice sites of the SLC22A9 gene for variants associated with autism spectrum disorder. With a diagnostic sensitivity exceeding 99.9%, this test is validated for detecting single nucleotide variants, small insertions/deletions, and copy number changes. Results are confirmed by Sanger sequencing to ensure maximal accuracy.
| Feature | Our SLC22A9 NGS Test | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | Targeted deep sequencing of SLC22A9 with >99.9% analytical sensitivity | Broad exome coverage, lower depth for single gene, ~95% sensitivity for point mutations |
| Methodology | Next‑Generation Sequencing (NGS) + Sanger confirmation | Whole Exome Sequencing without targeted confirmation |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize that the SLC22A9 gene is one of many factors in autism. Genetic testing can provide valuable insights but must be interpreted in the context of clinical evaluation and family history. Always consult with a genetic counselor before making decisions regarding your health.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue or alter any prescribed medication or supplement without consulting your treating physician. Genetic test results are for informational purposes and do not replace clinical judgment or medical advice.
Exclusion Criteria & Emergency Red Flags
- Patient is unable to provide informed consent (legal guardian required for minors).
- Suspected sample contamination or insufficient DNA yield.
- Acute psychiatric crisis or severe behavioral regression requiring immediate clinical intervention.
- ER Red Flags: New onset seizures, loss of previously acquired skills, self-harming behavior. Seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What does the SLC22A9 NGS test detect?
This next-generation sequencing test detects SLC22A9 gene mutations associated with autism spectrum disorder. It identifies single nucleotide variants, small insertions/deletions, and copy number changes within the coding region. The test is intended for patients with suspected genetic predisposition to autism and requires correlation with clinical findings.
2. What preparation is required before giving the sample?
Fasting is not required. Please provide a detailed clinical history and complete a pre‑genetic counseling session. For whole blood collection, no special preparation is needed; continue all medications as prescribed. The counseling session will include a pedigree chart review to guide interpretation.
3. How will I receive my results and what do they mean?
Results are delivered as a secure PDF report within 3–4 weeks, followed by a tele‑consultation for interpretation. The report classifies variants as pathogenic, likely pathogenic, or of uncertain significance. A DHA‑licensed clinician will guide you on clinical implications and next steps. A negative result does not exclude autism.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143 and strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, securely stored in UAE-based data centers, and accessed only by authorized clinical personnel. Patient consent is obtained per Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | SLC22A9 Gene Autism Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next‑Generation Sequencing (NGS) + Sanger Confirmation |
| ICD-10-CM Code | F84.0 |
| LOINC Code | 81203-7 |
| DHA Facility License & Laboratory Address | DHA Facility License: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians